Evidence map›Paper›PMID 31636483›Full record

ArticleTobacco use insights2019

Multimodal Smoking Cessation in a Real-Life Setting: Combining Motivational Interviewing With Official Therapy and Reduced Risk Products.

Pasquale Caponnetto, Jennifer DiPiazza, Giorgio Carlo Cappello, Shirin Demma, Marilena Maglia, Riccardo Polosa

Abstract read
In one paragraph

Article in Tobacco use insights, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pasquale CaponnettoCentro per la Prevenzione e Cura del Tabagismo, Azienda Ospedaliero-Universitaria, "V. Emanuele-Policlinico," Università di Catania, Catania, Italy.ORCID https://orcid.org/0000-0002-9368-5867
Jennifer DiPiazzaHunter-Bellevue School of Nursing, Hunter College, The City University of New York, New York, NY, USA.
Giorgio Carlo CappelloDipartimento di Filosofia e Comunicazione, Alma Mater Studiorum Università di Bologna, Italy.
Shirin DemmaCenter of Excellence for the acceleration of HArm Reduction (COEHAR), Dipartimento di Medicina clinica e sperimentale, University of Catania, Catania, Italy.
Marilena MagliaCenter of Excellence for the acceleration of HArm Reduction (COEHAR), Dipartimento di Medicina clinica e sperimentale, University of Catania, Catania, Italy.
Riccardo PolosaCentro per la Prevenzione e Cura del Tabagismo, Azienda Ospedaliero-Universitaria, "V. Emanuele-Policlinico," Università di Catania, Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTobacco use is a global pandemic, affecting an estimated 1.2 billion people and resulting in substantial health burdens and associated costs.

objectivesThe aim of this study was to estimate the efficacy of several treatments for smoking cessation in a real-life setting and to evaluate predictors of smoking abstinence.

methodsThis research was designed with a sample of 593 cases recorded over the period between 2015 and 2016. Six treatment groups were included: (1) bupropion and motivational interviewing (MI); (2) bupropion, nicotine replacement therapy (NRT), and MI; (3) NRT and MI; (4) varenicline and MI; (5) personal vaporizer electronic cigarette and MI; and (6) electronic cigarette, cigarette like "cigalike," and MI.

resultsResults support the efficacy of all treatment groups when used in a real-life setting. The predictors of smoking abstinence were sex, partner smoking status, previous quit attempts, daily consumption, self-efficacy, and level of nicotine dependence.

conclusionsThe use of different therapeutic strategies in clinical practice, including pharmacotherapy and nonstandard electronic nicotine delivery systems, such as an electronic cigarette, ensures a greater chance of cessation success and the possibility of tailoring interventions according to patients' resources.

Indexed as

bupropioncounselingelectronic cigaretteNRTSmoking cessationvarenicline

Identifiers

PMID31636483
PMCPMC6783661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.